Sequence Biotech Profile
Key Indicators
- Authorised Capital ₹ 2.50 Cr
- Paid Up Capital ₹ 1.92 Cr
- Company Age 16 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 5.40 Cr
- Revenue Growth -14.17%
- Profit Growth 1827.14%
- Ebitda 8.53%
- Net Worth 7.78%
- Total Assets -20.01%
About Sequence Biotech
Sequence Biotech Private Limited (SBPL) is a Private Limited Indian Non-Government Company incorporated in India on 19 September 2008 and has a history of 16 years and five months. Its registered office is in Nashik, Maharashtra, India.
The Corporate was formerly known as Sequence Bio-Tech Private Limited. The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 Cr and a paid-up capital of Rs 1.92 Cr.
The company currently has active open charges totaling ₹5.40 Cr.
Shrikant Bapat, Vijay Bibikar, Shriram Bhalerao, and Two other members serve as directors at the Company.
Company Details
- Location
Nashik, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U74999MH2008PTC186895
- Company No.
186895
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Sep 2008
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Sequence Biotech?
Board Members (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shriram Bhalerao  | Director | 02-Dec-2010 | Current |
| Shrikant Bapat | Director | 02-Dec-2010 | Current |
| Vijay Bibikar | Director | 02-Dec-2010 | Current |
| Rajendra Patil | Director | 19-Sep-2008 | Current |
| Sunita Aghav | Director | 19-Sep-2008 | Current |
Financial Performance of Sequence Biotech.
Sequence Biotech Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 14.17% decrease. The company also saw a substantial improvement in profitability, with a 1827.14% increase in profit. The company's net worth moved up by a moderate rise of 7.78%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sequence Biotech?
In 2022, Sequence Biotech had a promoter holding of 34.37% and a public holding of 65.63%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Vanaz Engineers LimitedShriram Bhalerao is a mutual person
Shrushti Realtors Private LimitedShriram Bhalerao is a mutual person
Shrikanchan Hotels And Resorts Private LimitedShrikant Bapat is a mutual person
Labindia Instruments Pvt LtdShrikant Bapat, Vijay Bibikar and 1 more are mutual person
Labindia Analytical Instruments Private LimitedShrikant Bapat, Vijay Bibikar and 1 more are mutual person
Charges (Loans)
₹5.40 Cr
₹0
Charges Breakdown by Lending Institutions
- Bank Of Maharashtra : 5.40 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 09 Jun 2011 | Bank Of Maharashtra | ₹5.40 Cr | Open |
How Many Employees Work at Sequence Biotech?
Sequence Biotech has a workforce of 11 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sequence Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sequence Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
